CEO
Adam Craig
Employees
128
Industry
Pharmaceutical Preparation Manufacturing
cti was founded on the belief that a coalition between unique scientific technology and its strong desire to “do right” by the patient could help us achieve our mission to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. we strive to do business better than other biopharmaceutical companies. better means a more collaborative, well-trained team environment willing to institute novel approaches to scientific discovery and business opportunities. a willingness to push the limits to achieve challenging goals is the essential attribute that sets cti employees apart.
Loading...
Open
9.10
Mkt cap
1.2B
Volume
5.6M
High
9.10
P/E Ratio
-16.84
52-wk high
9.10
Low
9.09
Div yield
N/A
52-wk low
4.01
Portfolio Pulse from Benzinga Newsdesk
May 24, 2023 | 12:41 pm
Portfolio Pulse from Lisa Levin
May 23, 2023 | 12:33 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.